Medical Industry News

A collection of Medical latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - GHO Capital - Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies
Excellere Partners and GHO Capital Sell Biocare Medical to Agilent Technologies
GlobeNewswire

Agilent to acquire Biocare in an all-cash transaction valued at $950 million Transaction follows significant period of growth under Excellere Partners and GHO Capital stewardship, with annual double-digit revenue and profit growth since 2021…

bloomberg.com - Liana Baker - Agilent Buys Medical Instruments Maker Biocare for $950 Million
Agilent Buys Medical Instruments Maker Biocare for $950 Million
Bloomberg

Agilent Technologies Inc. agreed to acquire privately held Biocare Medical, which makes instruments and materials used in cancer research, in an all-cash transaction valued at $950 million. Biocare will become part of the Agilent Life Sciences and…

bostonherald.com - Associated Press - Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Boston Herald

Getting your Trinity Audio player ready... By MICHELLE CHAPMAN, AP Business Writer Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo…

scmp.com - SCMP Editorial - Editorial | Medical school's biotech focus will boost Hong Kong's innovation push
Editorial | Medical school's biotech focus will boost Hong Kong's innovation push
South China Morning Post

Hong Kong is well served by its two traditional medical schools. A third school taking shape at the Hong Kong University of Science and Technology will add an innovative dimension to healthcare as well as a welcome boost to the supply of doctors.

pbs.org - Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration
Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration
PBS

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk's branded weight loss medicines sold through the Hims platform. Early last…

thehindu.com - Priyanka Dass - The many and varied medical uses of the placenta
The many and varied medical uses of the placenta
The Hindu

For many years, the placenta had been considered nothing more than clinical waste, a temporary organ that had served its sole purpose of sustaining a foetus, and was then disposed of. However, the medical community has now begun to see the placenta…

medpagetoday.com - Shannon Firth - Biden-Era Law Linked to Improved Medication Adherence in Medicare
Biden-Era Law Linked to Improved Medication Adherence in Medicare
Medpage Today

The Inflation Reduction Act, best known for Medicare drug-price negotiation, also contained provisions that capped out-of-pocket prescription drug costs. After the implementation of these provisions, Medicare Part D enrollees' cost-related…

stltoday.com - Dr. Roach: Looking at alternatives for osteoporosis medications
Dr. Roach: Looking at alternatives for osteoporosis medications
STLtoday.com

You have permission to edit this article. Get up-to-the-minute news sent straight to your device.

manchestereveningnews.co.uk - Bethan Finighan - Medication taken by millions linked to 'death risk' for dementia patients
Medication taken by millions linked to 'death risk' for dementia patients
Manchester Evening News

Dementia patients taking antidepressants or anti-anxiety medications may be at a higher risk of death, a new study has suggested. The study from Queen's University Belfast has shown, according to the lead author, that some medications 'may not…

wral.com - MICHELLE CHAPMAN — AP Business Writer - Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
WRAL News

Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have reached an agreement that will see Novo Nordisk's branded weight loss medicines sold through the Hims platform. Novo…

fool.com - James Hires - Forget Medical Properties Trust: This High-Quality Healthcare Landlord Is the Safer Dividend Play
Forget Medical Properties Trust: This High-Quality Healthcare Landlord Is the Safer Dividend Play
The Motley Fool

Due to their structure, most real estate investment trusts (REITs) have an attractive dividend yield. After all, they must pay out 90% of their taxable income to shareholders in the form of dividends. There are all kinds of REITs. They could be…

koreaherald.com - Choi Jeong-yoon - Seoul to expand medical tourism interpreters tenfold
Seoul to expand medical tourism interpreters tenfold
The Korea Herald

The Seoul Metropolitan Government said Monday it will expand its pool of medical tourism interpreter-coordinators to about 1,000 this year — nearly ten times the current level — to better serve the rapidly growing number of foreign…

koco.com - MICHELLE CHAPMAN - Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration
KOCO

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration As demand for GLP-1 weight loss drugs skyrockets, so does the risk of getting scammed. What we've been seeing in our scam tracker is advertisements…

marketbeat.com - Best Medical Stocks To Keep An Eye On - March 9th
Best Medical Stocks To Keep An Eye On - March 9th
MarketBeat

MarketBeat Week in Review – 02/23 - 02/27 Hims & Hers Health, UnitedHealth Group, Eli Lilly and Company, AbbVie, and Johnson & Johnson are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks…

deadline.com - Nellie Andreeva - Fox medical drama 'Doc' has landed a 22-episode Season 3 renewal, matching its Season 2 order. Barbie Kligman & Hank Steinberg continue as co-showrunners.
Fox medical drama 'Doc' has landed a 22-episode Season 3 renewal, matching its Season 2 order. Barbie Kligman & Hank Steinberg continue as co-showrunners.
Deadline

EXCLUSIVE: No sophomore slump for Fox ‘s Doc. After scoring a rare 22-episode Season 2 order with its breakout freshman run last year, the medical drama has done it again, landing a 22-episode Season 3 pickup. Barbie Kligman and Hank…

Receive a Daily briefing on Medical Industry News

Get Started